Understanding the Tumor Immune Microenvironment in Renal Cell Carcinoma

SIMPLE SUMMARY: Over the last decade there has been a significant increase in the number of therapies that activate the host’s immune system to target and eliminate renal cell carcinoma (RCC) tumors. The superior efficacy of these agents demonstrates that host control of RCC requires a robust and ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Shapiro, Daniel D., Dolan, Brendan, Laklouk, Israa A., Rassi, Sahar, Lozar, Taja, Emamekhoo, Hamid, Wentland, Andrew L., Lubner, Meghan G., Abel, Edwin Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177515/
https://www.ncbi.nlm.nih.gov/pubmed/37173966
http://dx.doi.org/10.3390/cancers15092500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177515/
https://www.ncbi.nlm.nih.gov/pubmed/37173966
http://dx.doi.org/10.3390/cancers15092500

Ejemplares similares